What role is #drugrepositioning to take in future drug development?

Interview of Aris Persidis to Total BioPharma’s Matt Turner

5 April 2012

“I see a very significant role for drug repositioning in current and also future drug development. Not only is it driven by the patent cliff, which is not a singular event but a continuous challenge, it is also contributing to innovation and novel insights in disease mechanisms. Drug repositioning based around so-called off-target effects can uncover unanticipated mechanisms in a disease, leading to new insights and potentially new classes of drugs in that disease. Given such developments, drug repositioning is on its way to becoming a staple of the drug development arsenal.”
Read More…